Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $952.68M.
ENTERPRISE VALUE (EV)
$952.68M
Ardelyx, Inc.
Market Cap
$812.73M
Enterprise Value (EV)
$952.68M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Ardelyx, Inc. (ARDX) | $812.73M | $952.68M |
| Jade Biosciences, Inc. (JBIO)vs › | $810.11M | $703.49M |
| InMode Ltd. (INMD)vs › | $803.87M | $412.15M |
| Gyre Therapeutics, Inc. (GYRE)vs › | $801.05M | $761.18M |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $834.66M | $782.54M |
| Alumis Inc. (ALMS)vs › | $837.55M | $810.27M |
| Beta Bionics, Inc. (BBNX)vs › | $838.83M | $801.03M |
| AdaptHealth Corp. (AHCO)vs › | $786.84M | $2.81B |
| QuidelOrtho Corporation (QDEL)vs › | $841.30M | $3.79B |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $841.35M | $619.84M |
Market Cap
$812.73M
Total Debt
$207.95M
Cash
$68.00M
Enterprise Value
$952.68M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
